1,342
Views
8
CrossRef citations to date
0
Altmetric
Review

Nutrition in sickle cell disease: recent insights

&
Pages 9-17 | Published online: 23 May 2019

References

  • Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38(Suppl):S512–S521. doi:10.1016/j.amepre.2009.12.022
  • Weatherall DJ. Hemoglobinopathies worldwide: present and future. Curr Mol Med. 2008;8:592–599. doi:10.2174/156652408786241375
  • Steiner CA, Miller JL. Sickle cell disease patients in U.S. hospitals, 2004. Statistical brief. No. 21. Rockville (MD): Agency for Healthcare Research and Quality; December 2006.
  • Davis H, Moore RM Jr, Gergen PJ. Cost of hospitalizations associated with sickle cell disease in the United States. Public Health Rep. 1997;112(1):40.
  • Platt OS. Hydroxyurea for the treatment of sickle cell anemia. N Engl J Med. 2008;358:1362–1369. doi:10.1056/NEJMct0708272
  • Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639–1644.
  • Egberg MD. Progressive loss of brain volume in children with sickle cell anemia and silent cerebral infarct: a report from the silent cerebral infarct transfusion trial. Correspondence. Am J Hematol. 2018:E406.
  • Hyacinth HI. Sickle-cell anaemia needs more food? Lancet Haematol. 2018;5(4):e130. doi:10.1016/S2352-3026(18)30032-2
  • Daak A, Rabinowicz A, Ghebremeskel K. Omega three fatty acids are a potential therapy for patients with sickle cell disease. Nat Rev Dis Primers. 2018;4, Article number:15. doi:10.1038/s41572-018-0012-9
  • Adegoke SA, Smith OS, Adekile AD, Figueiredo MS. Relationship between serum 25-hydroxyvitamin D and inflammatory cytokines in paediatric sickle cell disease. Cytokine. 2017;96:87–93. Epub 2017 Apr 5. doi:10.1016/j.cyto.2017.03.010
  • Heyman MB, Katz R, Hurst D, et al. Growth retardation in sickle-cell disease treated by nutritional support. Lancet. 1985;325:903–906. doi:10.1016/S0140-6736(85)91677-0
  • Manci EA, Hyacinth HI, Capers PL, et al. High protein diet attenuates histopathologic organ damage and vascular leakage in transgenic murine model of sickle cell anemia. Exp Biol Med (Maywood). 2014;239(8):966–974. Epub 2014 May 19. doi:10.1177/1535370214531863
  • Archer DR, Stiles JK, Newman GW, et al. C-reactive protein and Interleukin-6 are decreased in transgenic sickle cell mice fed a high protein diet. J Nutr. 2008;138:1148–1152. doi:10.1093/jn/138.6.1148
  • Hibbert JM, Forrester T, Jackson AA. Urea kinetics: comparison of oral and intravenous dose regimens. Eur J Clin Nutr. 1992;46:405–409.
  • Hibbert JM, Creary MS, Gee BE, et al. Erythropoiesis and myocardial oxygen consumption contribute significantly to hypermetabolism of childhood sickle cell anemia. J Pediatr Gastroenterol Nutr. 2006;43:680–687.
  • Hibbert JM, Hsu LL, Bhathena SJ, et al. Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease. Exp Biol Med. 2005;230:68–74. doi:10.1177/153537020523000109
  • Singhal A, Parker S, Linsell L, Serjeant G. Energy intake and resting metabolic rate in preschool Jamaican children with homozygous sickle cell disease. Am J Clin Nutr. 2002;75:1093–1097. doi:10.1093/ajcn/75.6.1093
  • Morris CR. Alterations of the arginine metabolome in sickle cell disease. A growing rationale for arginine therapy. Hematol Oncol Clin N Am. 2014;28:301–321. doi:10.1016/j.hoc.2013.11.008
  • Kehinde MO, Ogungbemi SI, Anigbogu CN, Jaja SI. L-Arginine supplementation enhances antioxidant activity and erythrocyte integrity in SCA subjects. Pathophysiology. 2015;22:137–142. doi:10.1016/j.pathophys.2015.05.001
  • Cox SE, Ellins EA, Marealle AI, et al. Ready-to-use- food supplement, with or without arginine and citrulline, with daily chloroquine in Tanzanian children with sickle-cell disease: a double-blind, random order crossover trial. Lancet. 2018;5:e147–e160. doi:10.1016/S2352-3026(18)30020-6
  • Bondonno CP, Blekkenhorst LC, Liu AH, et al. Vegetable-derived bioactive nitrate and cardiovascular health. Mol Aspects Med. 2018;61:83–91. doi:10.1016/j.mam.2017.08.001
  • Kobayashi J, Ohtake K, Uchida H. NO-rich diet for lifestyle-related disease. Nutrients. 2015;7:4911–4937. doi:10.3390/nu7064911
  • Little JA, Hauser KP, Martyr SE, et al. Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy. Eur J Haematol. 2009;82:315–321. doi:10.1111/j.1600-0609.2009.01210.x
  • Gizi A, Papassotiriou I, Apostolakou F, et al. Assessment of oxidative stress in patients with sickle cell disease: the glutathione system and the oxidant-antioxidant status. Blood Cells Mol Dis. 2011;46:220–225. doi:10.1016/j.bcmd.2011.01.002
  • Williams R, Olivi S, Li CS, et al. Oral glutamine supplementation decreases resting energy expenditure in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol. 2004;26(10):619–625. doi:10.1097/01.mph.0000140651.65591.b8
  • Niihara Y, Matsui NM, Shen YM, et al. L-Glutamine therapy reduces endothelial adhesion of sickle red blood cells to human umbilical vein endothelial cells. BMC Blood Disord. 2005;5:4.
  • DeBaun MR, Vichinsky P. Vaso-occlusive pain management in sickle cell disease. UpToDate. 2018;1–52.
  • Quinn CT. L-gutamine for sickle cell anemia: more questions than answers. Blood. 2018;132(7):689. doi:10.1182/blood-2018-03-834440
  • Minniti CP. L-glutamine and the dawn of combination therapy for sickle cell disease. New Egl J Med. 2018;379(3):292–294. doi:10.1056/NEJMe1800976
  • McCaskill ML, Ogunsakin O, Hottor T, Harville E, Kruse-Jarres R. Serum 25-hydroxyvitamin D and diet mediates vaso-occlusive related hospitalizations in sickle cell disease patients. Nutrients. 2018;10(10):1–15. doi:10.3390/nu10101384
  • Bikle DD. Extraskeletal actions of vitamin D. Ann NY Acad Sci. 2016;1376(1):29–52. doi:10.1111/nyas.13219
  • Wei R, Christakos S. Mechanisms underlying the regulation of innate and adaptive immunity by vitamin D. Nutrients. 2015;7(10):8251–8260. doi:10.3390/nu7105392
  • Lee MT, Kattan M, Fennoy I, et al. Randomized phase 2 trial of monthly vitamin D to prevent respiratory complications in children with sickle cell disease. Blood Adv. 2018;2(9):969–978. doi:10.1182/bloodadvances.2017013979
  • Rinehart J, Gulcicek EE, Joiner CH, Lifton RP, Gallagher PG. Determinants of erythrocyte hydration: current opinion in hematogy. Curr Opin Hematol. 2010;17(3):191–197. doi:10.1097/MOH.0b013e32833800d0
  • Piel FB, Steinberg MH, Rees DC. Sickle cell disease. N Engl J Med. 2017;376(16):1561–1573. doi:10.1056/NEJMra1510865
  • Diaw M, Samb A, Diop S, et al. Effects of hydration and water deprivation on blood viscosity during a soccer game in sickle cell trait carriers. British J of Sports Med. 2014;48(4):326–331. doi:10.1136/bjsports-2012-091038
  • Williams-Hooker R, Hankins J, Ringwald-Smith K, et al. Evaluation of hydration status, sodium and fluid intake in children with sick cell anaemia. J Blood Disord Transf. 2013;4(3):1–4. doi:10.4172/2155-9864.1000143
  • Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol. 2012;9(10):577–589. doi:10.1038/nrgastro.2012.156
  • Bayram B, Gonzalez-Sarrias A, Istas G, et al. Breakthrough in the health effects of plant food bioactives; A perspective on microbiomics, Nutri(epi)genomics, and metabolomics. J Agric Food Chem. 2018;66(41):10686–10692. doi:10.1021/acs.jafc.8b03385
  • Zhang D, Chen G, Manwani D, et al. Neutrophil ageing is regulated by the microbiome. Nature. 2015;525(7570):528–532. doi:10.1038/nature15367
  • Tiso M, Schechter AN. Nitrate reduction to nitrite, nitric oxide and ammonia by gut bacteria under physiological conditions. PLoS One. 2015. doi:10.1371/journal.pone.0119712
  • Lim SH, Fast L, Morris A. Sickle cell vaso-occlusive crisis: it’s a gut feeling. J Transl Med. 2016;14(1):334–336. doi:10.1186/s12967-016-1092-5
  • Lim SH, Morris A, Li K, et al. Intestinal microbiome analysis revealed dysbiosis in sickle cell disease. Am J Hematology. 2018;93(4):E91–E93. doi:10.1002/ajh.25019
  • Khan SA, Damanhouri G, Ali A, et al. Precipitating factors and targeted therapies in combating the perils of sickle cell disease – A special nutritional consideration. Nutr Metab (Lond). 2016;13(50):1–12. doi:10.1186/s12986-016-0109-7
  • Wright RJ, Lee KS, Hyacinth HI, et al. An investigation of the antioxidant capacity in extracts from moringa oleifera plants grown in jamaica. Plants. 2017;6(48):1–8. doi:10.3390/plants6040048
  • Nurain IO, Bewaji CO, Johnson JS, et al. Potential of three ethnomedicinal plants as anti-sickling agents. Mol Pharm. 2017;14(1):172–182. doi:10.1021/acs.molpharmaceut.6b00767
  • Tang R, Tian R, Cai J, et al. Acute and sub-chronic toxicity of Cajanus cajan leaf extracts. Pharm Biol. 2017;55(91):1740–1746. doi:10.1080/13880209.2017.1309556